Stroma-Free Human Hemoglobin A Decreases R3230Ac Rat Mammary Adenocarcinoma Blood Flow and Oxygen Partial Pressure

• Published in: Radiation research 1997-02, Vol.147 (2), p.185-194
• Main Authors: Hahn, Jason S., Braun, Rod D., Dewhirst, Mark W., Shan, Siqing, Snyder, Stacey A., Taube, Janis M., Ong, Edgardo T., Rosner, Gary L., Dodge, Richard K., Bonaventura, Joseph, Bonaventura, Celia, DeAngelo, Joseph, Meyer, Robert E.
• Format: Article
• Language: English
• Subjects: Adenocarcinoma - blood supply; Adenocarcinoma - physiopathology; Albumins; Animals; Arterioles; Arterioles - drug effects; Biological and medical sciences; Blood flow; Blood Pressure - drug effects; Cell Hypoxia; Female; Heart Rate - drug effects; Hemoglobin A - pharmacology; Hemoglobins; Humans; Hypoxia; Investigative techniques of hemodynamics; Investigative techniques, diagnostic techniques (general aspects); Mammary Neoplasms, Experimental - blood supply; Mammary Neoplasms, Experimental - physiopathology; Medical sciences; Miscellaneous; Nitric Oxide - antagonists & inhibitors; Oxides; Oxygen; Oxygen - metabolism; Oxygen - pharmacology; Oxygen partial pressure; Partial Pressure; Quadriceps muscle; Rats; Rats, Inbred F344; Regional Blood Flow - drug effects; Space life sciences; Tumors; Vasoconstriction - drug effects
• ISSN: 0033-7587; 1938-5404
• DOI: 10.2307/3579420

We examined the effect of a nitric oxide (NO) quencher, stroma-free human hemoglobin A (${\rm HbA}_{0}$; 0.01, 0.05, 0.1, 0.2 g/kg), on the blood flow measured using the Doppler flow technique, tumor oxygen pressure ($p{\rm O}_{2}$) and the diameter of the arterioles using R3230Ac mammary adenocarcinoma as the tumor model. In female Fischer 344 rats with 1-cm-diameter tumors implanted in the lateral aspect of the left quadriceps, intravenous infusion of 0.1 and 0.2 g/kg ${\rm HbA}_{0}$ decreased both central tumor and peripheral tumor blood flow by 20-30% (P < 0.05). Tumor $p{\rm O}_{2}$ decreased 28% with 0.2 g/kg ${\rm HbA}_{0}$, from 15 mm Hg (baseline) to 11 mm Hg at 10 min (P = 0.02). Although 0.2 g/kg ${\rm HbA}_{0}$ increased blood flow 55% in the left quadriceps muscle proximal to the implanted tumor (P < 0.05), ${\rm HbA}_{0}$ had little effect on blood flow in right quadriceps muscle with no tumor implanted, and increased right quadriceps $p{\rm O}_{2}$, from 21 mm Hg (baseline) to 23 mm Hg at 10 min (P = 0.03). ${\rm HbA}_{0}$ increased mean arterial pressure 5-10% in a manner that was dependent on dose while heart rate concurrently decreased 9-19%. The diameter of the arterioles supplying the tumor was rapidly reduced 10% by 0.2 g/kg ${\rm HbA}_{0}$ (P = 0.037) and remained stable through 60 min of observation (P = 0.005). ${\rm HbA}_{0}$ selectively reduces tumor blood flow and tumor $p{\rm O}_{2}$ through vasoconstriction of the arterioles supplying the tumor. Vascular NO quenching provides an alternative to NO synthase inhibition as a means to achieve the goal of selective tumor hypoxia.